Crystal clear: could unlocking proteins provide new cures for anxiety?
Earlier this year, a research team at Michigan State University (MSU) managed to reveal, for the first time, the crystal…
All articles by Heidi Vella
Heidi Vella
-
-
Draining cancer’s fuel tank
Cancer stem cells have long been the subject of intensive research. Since they were first identified, the scientific community has…
-
A new ERA for pulmonary arterial hypertension patients in England
Thanks to the recent approval of a new drug developed by Actelion, patients in England with life-threatening orphan disease pulmonary…
-
Boehringer to close manufacturing lab, losing 1,100 jobs
Boehringer Ingelheim GmbH has announced plans to shutdown its Ben Venue Laboratories unit by the end of the month, cutting…
-
GSK and Genmab seek alternative approval for leukaemia drug Arzerra
GlaxoSmithKline and Genmab A/S have announced the submission of leukaemia drug Arzerra to the European Medicines Agency (EMA) for a…
-
Aerial Biopharma announce positive Phase II results for narcolepsy drug
A new drug to treat excessive daytime sleepiness associated with narcolepsy has shown positive results from a phase 2b clinical…
-
Common blood pressure drug could help fight tumours
A common blood pressure drug marketed by Merck & Co could help fight cancer tumours, a recent study on mice…
-
UK’s cancer drug fund extended to 2016
A £200m-a-year cancer drugs fund due to expire next year will be extended until 2016, UK Prime Minister David Cameron…
-
Boehringer Ingelheim cancer drug shows positive results in Phase III trial
Boehringer Ingelheim's LUME-Lung 1 Phase III clinical trial of novel investigational compound nintedanib has provided a significant and clinically relevant…
-
UK cancer study group to co-fund research into new cancer treatment
The Cancer Research Technology Pioneer Fund CPF has announced it has chosen a study to develop a promising class of…